Only combined metformin and vildagliptin exert better benefits by reduced cardiac arrhythmia score and arrhythmic death during I/R injury in obese-insulin resistant rats by increasing Cx-43 phosphorylation. This evidence concerns the gene GJA1 and cardiac rhythm disease.